Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/15/00 → 2/28/02 |
Funding
- Inhalation Technology Inc: $162,397.00
BT0002--A Single-Dose, Open Label, Randomized, Three-Way Crossover, Bioavailability Study of 1.0 and 2.0 mg Intranasal Butorphanol Tartrate Compared to 2.0 mg Intravenous Butophanol Tartrate in Health Young Volunteers
- Davis, George (PI)